Department of Radiation Oncology, University of Washington, Seattle, WA, United States of America.
Department of Cardiology, University of Washington, Seattle, WA, United States of America.
Cardiovasc Revasc Med. 2024 Feb;59:29-34. doi: 10.1016/j.carrev.2023.08.014. Epub 2023 Sep 1.
To evaluate coronary artery integrity after very high radiation doses from intravascular brachytherapy (IVBT) in the setting of source asymmetry.
Ten patients treated for right coronary artery (RCA) in-stent restenosis (ISR) between 2017 and 2021 and for whom follow-up angiograms were available were identified from departmental records. Procedural angiograms, taken to document source position, were used to estimate vascular wall doses. The 2.5 mm proximal source marker was used to estimate the distance from source center to the media and adventitia. Distances were converted to dose (Gy) using the manufacturers' dose fall-off table, measured in water. Follow-up films were scrutinized for any sign of late vascular damage.
The average minimal distance from catheter center to the adjacent media and the adventitia was 0.9 mm (±0.2) mm and 1.4 mm (±0.2), respectively. The average maximum media and adventitial doses adjacent to the source were 75 Gy (±26) and 39 Gy (±14), respectively. Follow-up angiograms were available from 0.6 years to 3.9 years following IVBT (median: 1.6 years). No IVBT-treated vascular segment showed signs of degeneration, dissection or aneurysm.
IVBT vascular wall doses are frequently far higher than prescribed. The lack of complications in this unselected group of patients gives a modicum of reassurance that raising the prescription dose is unlikely to lead to a sudden appearance of complications.
评估血管内近距离放射治疗(IVBT)中源不对称时极高放射剂量对冠状动脉完整性的影响。
从科室记录中确定了 10 名 2017 年至 2021 年间接受右冠状动脉(RCA)支架内再狭窄(ISR)治疗且有随访血管造影的患者。为记录源位置而进行的程序血管造影被用于估计血管壁剂量。使用 2.5mm 近端源标记来估计从源中心到中膜和外膜的距离。距离使用制造商的剂量衰减表转换为剂量(Gy),在水中测量。随访片被仔细检查是否有晚期血管损伤的迹象。
导管中心到相邻中膜和外膜的平均最小距离分别为 0.9mm(±0.2)mm 和 1.4mm(±0.2)mm。紧邻源的平均最大中膜和外膜剂量分别为 75Gy(±26)和 39Gy(±14)。IVBT 后 0.6 年至 3.9 年(中位数:1.6 年)获得随访血管造影。没有 IVBT 治疗的血管段显示退化、夹层或动脉瘤的迹象。
IVBT 血管壁剂量经常远高于规定剂量。在未选择的患者组中没有出现并发症,这给人带来了一定的安慰,即提高处方剂量不太可能导致并发症突然出现。